NXTC NextCure, Inc.
Healthcare$7.05+0.00%OpenMarket Cap: $18.9M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$15.00
Target (Median)
$15.00
Target Range
$15.00 - $15.00
Upside from current price: 112.8%
Rating Distribution
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-11-07 | Ladenburg Thalmann | upgrade | Buy | Neutral |
| 2025-07-15 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-07-01 | HC Wainwright & Co. | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-8.35 | $7.0M | 2 |
| Sun Dec 31 | $-5.49 | $10.3M | 1 |
| Mon Dec 31 | $-5.28 | $22.6M | 1 |
| Tue Dec 31 | $-5.14 | $39.7M | 1 |